Valuation Alaunos Therapeutics, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-10-02 EDT			5-day change	1st Jan Change
0.8200 ^USD	-10.87%		-18.58%	-71.52%

08-14	Alaunos Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-29	Alaunos Therapeutics Reports New Preclinical ALN1003 Data Showing Lower Liver Weight After Adjustment For Body Fat Percentage In 48-Day DIO Mouse Study	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	536.6	234	155.4	16.98	3.05	7.209
Change	-	-56.4%	-33.56%	-89.08%	-82.04%	136.32%
Enterprise Value (EV) ¹	426.3	187.3	135.9	10.92	1.959	5.824
Change	-	-56.08%	-27.43%	-91.96%	-82.06%	197.23%
P/E	-6.61x	-2.97x	-3.74x	-0.48x	-0.65x	-1.47x
PBR	4.35x	4.04x	4.03x	2.69x	1.48x	3.52x
PEG	-	0.8x	0.1x	0x	0x	0.1x
Capitalization / Revenue	-	587,819,588x	53,196,617x	3,396,281,000x	305,038,500x	1,441,761,400x
EV / Revenue	-	-	-	-	-	-
EV / EBITDA	-5.38x	-2.52x	-4.53x	-0.42x	-0.41x	-1.38x
EV / EBIT	-5.31x	-2.44x	-4.15x	-0.38x	-0.41x	-1.38x
EV / FCF	-11.8x	-5.36x	-4.86x	-2.14x	-0.59x	-7.73x
FCF Yield	-8.45%	-18.7%	-20.6%	-46.7%	-168%	-12.9%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-57.22	-55.1	-26.06	-22	-2.922	-2.198
Distribution rate	-	-	-	-	-	-
Net sales	-	0.398	2.922	0.005	0.01	0.005
EBITDA ¹	-79.23	-74.21	-29.98	-26.18	-4.81	-4.218
EBIT ¹	-80.36	-76.81	-32.74	-28.49	-4.812	-4.225
Net income ¹	-79.98	-78.75	-37.73	-35.14	-4.679	-4.176
Net Debt ¹	-110.3	-46.69	-19.55	-6.062	-1.091	-1.385
Reference price ²	377.9998	163.4999	97.3650	10.6050	1.9050	3.2300
Nbr of stocks (in thousands)	1,420	1,431	1,596	1,601	1,601	2,232
Announcement Date	3/1/21	3/30/22	3/7/23	4/1/24	3/31/25	3/31/26

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ALAUNOS THERAPEUTICS, INC.	-	-	-	-	2.08M
WUXI APPTEC CO., LTD.	21.73x	7.71x	15.48x	1.37%	74.16B
ARGENX SE	29.82x	8.57x	26.7x	0.04%	57.39B
LONZA GROUP AG	32.98x	5.93x	17.77x	0.98%	47.64B
REVOLUTION MEDICINES, INC.	-21.31x	230.81x	-22.97x	-.--%	44.29B
IQVIA HOLDINGS INC.	33.26x	3.23x	13.97x	-.--%	42.5B
BEONE MEDICINES AG	46.77x	5.41x	29.66x	-.--%	40.71B
CELLTRION, INC.	27.63x	7.93x	20.48x	0.41%	30.97B
WUXI BIOLOGICS (CAYMAN) INC.	32.99x	7.05x	18.3x	-.--%	28.53B
BIONTECH SE	-15.1x	5.68x	-7.14x	-.--%	24.34B
Average	20.98x	31.37x	12.47x	0.31%	39.05B
Weighted average by Cap.	22.27x	32.04x	13.55x	0.42%